Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/139999
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPourmehran, O.-
dc.contributor.authorZarei, K.-
dc.contributor.authorPourchez, J.-
dc.contributor.authorVreugde, S.-
dc.contributor.authorPsaltis, A.-
dc.contributor.authorWormald, P.-J.-
dc.date.issued2023-
dc.identifier.citationInternational Journal of Pharmaceutics, 2023; 644:123277-1-123277-18-
dc.identifier.issn0378-5173-
dc.identifier.issn1873-3476-
dc.identifier.urihttps://hdl.handle.net/2440/139999-
dc.descriptionAvailable online 27 July 2023-
dc.description.abstractChronic rhinosinusitis (CRS) impacts patients' quality of life and healthcare costs. Traditional methods of drug delivery, such as nasal sprays and irrigation, have limited effectiveness. Acoustic Drug Delivery (ADD) using a nebulizer offers targeted delivery of drug to the sinuses, which may improve the treatment of CRS. This review examines the influence of aerosol particle characteristics, aero-acoustic parameters, inlet flow conditions, and acoustic waves on sinus drug delivery. Key findings reveal that smaller particles improve the ADD efficiency, whereas larger sizes or increased density impair it. The oscillation amplitude of the air plug in the ostium is crucial for the ADD efficiency. Introducing acoustic waves at the NC-sinus system's resonance frequency improves aerosol deposition within sinuses. Future research should address advanced models, optimizing particle characteristics, investigating novel acoustic waveforms, incorporating patient-specific anatomy, and evaluating long-term safety and efficacy. Tackling these challenges, ADD could offer more effective and targeted treatments for sinus-related conditions such as CRS.-
dc.description.statementofresponsibilityOveis Pourmehran, Kavan Zarei, Jeremie Pourchez, Sarah Vreugde, Alkis Psaltis, Peter-John Wormald-
dc.language.isoen-
dc.publisherElsevier BV-
dc.rights© 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).-
dc.source.urihttp://dx.doi.org/10.1016/j.ijpharm.2023.123277-
dc.subjectAcoustic Drug Delivery-
dc.subjectChronic Rhinosinusitis-
dc.subjectDrug Delivery-
dc.subjectNasal Cavity-
dc.subjectParanasal Sinuses-
dc.subject.meshParanasal Sinuses-
dc.subject.meshHumans-
dc.subject.meshSinusitis-
dc.subject.meshChronic Disease-
dc.subject.meshAdministration, Intranasal-
dc.subject.meshAcoustics-
dc.subject.meshQuality of Life-
dc.subject.meshRespiratory Aerosols and Droplets-
dc.titleAdvancements in Acoustic Drug Delivery for Paranasal Sinuses: A Comprehensive Review-
dc.typeJournal article-
dc.identifier.doi10.1016/j.ijpharm.2023.123277-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/2014977-
pubs.publication-statusPublished-
dc.identifier.orcidVreugde, S. [0000-0003-4719-9785]-
dc.identifier.orcidPsaltis, A. [0000-0003-2967-1855]-
dc.identifier.orcidWormald, P.-J. [0000-0001-7753-7277]-
Appears in Collections:Surgery publications

Files in This Item:
File Description SizeFormat 
hdl_139999.pdfPublished version13.36 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.